
According to a recent research study titled "Methionine Aminopeptidase 2 (Initiation Factor 2 Associated 67 kDa Glycoprotein or Peptidase M 2 or eIF 2 Associated p67 Homolog or METAP2 or EC 3.4.11.18)-Pipeline Review, H2 2017" which has been added to the comprehensive database of Market Research Hub (MRH), there are 13 molecules, of which 11 are developed by companies and remaining 2 are developed by universities. These 13 molecules are in various stages of drug development, including discovery, preclinical, Phase I, Phase II, and Phase III. The report discusses pipeline review in detail and offers holistic information on the basis of various segments.